InvestorsHub Logo
icon url

doogdilinger

02/08/13 10:00 AM

#1293 RE: dr_c6 #1292

Analysts at Maxim Group initiated coverage on shares of Intellipharmaceutics in a research note to investors on Thursday, January 31st. They set a buy rating and a $7.00 price target on the stock.